These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| þ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
SYMBID CORP.
|
|||
|
(Exact name of registrant as specified in its charter)
|
|||
|
Nevada
|
45-2859440
|
||
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
||
|
Marconistraat 16, 3029 AK Rotterdam, The Netherlands
|
10022
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
+31(0)1 041 34 601
|
|
|
(Registrant’s telephone number, including area code)
|
|
|
Large Accelerated Filer
o
|
Accelerated Filer
o
|
|
|
Non-Accelerated Filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
þ
|
|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
3
|
||||
|
EXPLANATORY NOTE
|
3
|
||||
|
PART I
|
5
|
||||
|
ITEM 1.
|
BUSINESS
|
5
|
|||
|
ITEM 1A.
|
RISK FACTORS
|
29
|
|||
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
38
|
|||
|
ITEM 2.
|
PROPERTIES
|
38
|
|||
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
38
|
|||
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
38
|
|||
|
PART II
|
|||||
|
ITEM 5.
|
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
39
|
|||
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
40
|
|||
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
41
|
|||
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
49
|
|||
|
ITEM 8.
|
CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
50
|
|||
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
50
|
|||
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
50
|
|||
|
ITEM 9B.
|
OTHER INFORMATION
|
52
|
|||
|
PART III
|
|||||
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
|
52
|
|||
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
55
|
|||
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
57
|
|||
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
59
|
|||
|
ITEM 14.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
60
|
|||
|
PART IV
|
|||||
|
ITEM 15.
|
EXHIBITS, FINANCIAL STATEMENT SCHEDULES
|
61
|
|||
|
SIGNATURES
|
64
|
||||
|
|
BUSINESS
|
|
ü
|
Equity based: crowdfunding for financial return through revenue and profit sharing;
|
|
ü
|
Lending based: crowdfunding for financial return through interest on a loan; and
|
|
ü
|
Reward/donation based: crowdfunding for non-monetary rewards or corporate partnership.
|
|
ü
|
Flexibility in the model of crowdfunding -
all models of crowdfunding can be offered through the Symbid platform;
|
|
ü
|
Internationalization -
the Symbid platform will be provided in different languages for different countries (currently available in Dutch and English);
|
|
ü
|
Partnering – the Symbid product offering will be sold through
premium resellers;
|
|
ü
|
Stand-alone application -
usage of the Symbid platform in a closed environment; and
|
|
ü
|
Offering of additional services -
Symbid is a founding partner in several crowdfunding related service companies.
|
|
Gambitious B.V.
|
Gambitious was organized on December 5, 2011, in The Netherlands as a limited liability company, to operate a crowdfunding platform in the video-games industry under an exclusive Symbid license. Gambitious is Symbid’s first partner operating in a specific niche industry. This company, led by a management team of video game experts, received external seed financing from industry veterans and a “crowd” of Symbid investors in 2012. Started as an in-house project at Symbid and co-founded by Symbid, Gambitious became a Symbid spin-out in 2012. Symbid initially owned a 50% interest in Gambitious, which interest was subsequently diluted through additional financings. Symbid now owns an indirect 13.05% interest in Gambitious B.V., which it holds through a 46% membership interest in Gambitious Cooperatie U.A., a limited liability cooperative formed in The Netherlands and the holding company for Symbid’s interest in Gambitious B.V.
|
|
Equidam Holding B.V.
|
Equidam, founded in August 2013, is one of the first companies to be organized in any country as a crowdfunding service provider. Started as an online valuation tool for private companies with a particular focus on Small and Medium-sized Enterprises, Equidam now also offers monitoring services to investors on the Symbid platform. In addition to Equidam’s relationship with Symbid, this company has entered partnerships with European crowdfunding platforms to provide its services to these platforms as well. Symbid owns a 9% direct interest in Equidam.
|
|
●
|
Startup entrepreneurs
|
|
●
|
Experienced entrepreneurs
|
|
●
|
Friends, Family, Fools investors
|
|
●
|
Retail investors
|
|
●
|
Business angel investors
|
|
●
|
Financial advisors
|
|
●
|
Websites for (private) investors
|
|
●
|
Websites promoting crowdfunding propositions
|
|
●
|
General websites
|
|
●
|
Financial advisors
|
|
●
|
Business coaches
|
|
●
|
(Web)Communities
|
|
●
|
Brokers
|
|
●
|
Informal investor networks (group deals)
|
|
●
|
VC’s (market testing/ additional liquidity)
|
|
●
|
Business plan competition (added value)
|
|
●
|
Incubators (added value)
|
|
●
|
Investment clubs/ groups
|
|
●
|
Entrepreneurial coaching companies
|
|
●
|
Internet communities
|
|
●
|
Capital search companies
|
|
●
|
Alumni networks
|
|
●
|
Pitch Events/ Demo days
|
|
1.
|
Associate their brand with Symbid/crowdfunding
|
|
2.
|
Get access to Symbid user base for special offers and deals
|
|
3.
|
Use Symbid as an outsourced R&D department within this new market
|
|
4.
|
Get database access for research purposes
|
|
●
|
Banks
|
|
●
|
Insurance companies
|
|
●
|
OEM
|
|
●
|
Telco
|
|
●
|
Publishers
|
|
●
|
Bookkeeping software
|
|
ü
|
Transaction fees
– For every transaction a fee of 2.5% is charged.
|
|
ü
|
Success fee
– When reaching a funding target, 5% of the target capital is charged.
|
|
ü
|
White label licenses
-
Symbid offers stand-alone and white label versions of its crowdfunding platform to partners, companies and other (educational) organizations.
Stand-alone versions of the crowdfunding platform operate independently in a closed environment while white label versions are interconnected with the Symbid crowdfunding platform allowing for interaction with Symbid platform users.
Target net revenue per partner is $10,000 for the set-up and a yearly license fee to cover maintenance costs.
|
|
ü
|
Software licenses
–
Symbid offers exclusive licenses within a country to use the Symbid legal and technology infrastructure. Set-up fees are at a minimum of $33,000 and yearly license fees will be offered for a minimum of $13,000 per year;
|
|
ü
|
Affiliate and Group licenses
– Symbid offers owners of existing communities or groups a crowdfunding service so they do not require their own crowdfunding infrastructure. Prices range from $700 to $2,500 on a yearly basis.
|
|
ü
|
Corporate Partnerships
– Large corporates want to engage with the communities of investors and entrepreneurs in the Symbid eco-system. Symbid is offering corporate partnerships for those companies ranging from $7,000 to $100,000.
|
|
ü
|
To serve a large base of people on any given platform, it is critical that Symbid can operate as matchmaker, much like a dating service, with the highest degree of accessibility possible;
|
|
ü
|
Serious/professional investors will require a quality infrastructure and best practices, Symbid has been developing these best practices since its inception;
|
|
ü
|
To offer an infrastructure which supports the financial model on a global scale and works for both entrepreneurs and investors;
|
|
ü
|
Local responsiveness of Symbid is required in order to roll out the infrastructure on a global scale;
|
|
ü
|
Partners, third-party analysts, researchers, potential suppliers and experts must be able to tap into and spread the content of the platform, much like is done for the public equity marketplace using social networks like Facebook and Twitter;
|
|
ü
|
Standardized flows of information for both investors and entrepreneurs must be provided, to increase the efficiency of the transaction for all parties involved.
|
|
HOLDING LEVEL
|
COUNTRY LEVEL
|
|
|
Positioning strategy
Product strategy
Partnering strategy
Acquisition strategy
Financial planning
Execution plan
|
Country sales
HR and Partner management
Country marketing
Customer support
Event management
Proposition
management
|
|
●
|
Having an established reputation for delivering leading products and services;
|
|
●
|
A willingness to pro-actively collaborate with channel partners;
|
|
●
|
Adoption of industry leading marketing strategies, such as the use of plain English explanations what crowdfunding is; and
|
|
●
|
An aggressive marketing strategy fueled by an extensive marketing budget.
|
|
Emotional values
|
Functional values
|
|
Connection
|
Simplify direct participation
|
|
Collectively
|
Return in the form of value creation
|
|
Transparency
|
Professional and trustworthy
|
|
●
|
Extend product offering with lending based crowdfunding;
|
|
●
|
Create continuous interaction on the platform between all actors in the crowdfunding eco-sphere;
|
|
●
|
Extend geographic reach by making the Symbid platform accessible in more and more languages; and
|
|
●
|
Improve responsiveness in delivery of group, affiliate and portal services by creating an in-house IT department over time.
|
|
●
|
Increase the number of fully legally serviceable countries worldwide;
|
|
●
|
Increase in its relationships with local financial authorities;
|
|
●
|
Maintain the upmost service level towards country partners; and
|
|
●
|
Maintain Symbid’s high governance standard toward its legal framework.
|
|
●
|
Attracting deals and investors;
|
|
●
|
Business (e)-valuation and monitoring; and
|
|
●
|
Offering value added services for the companies.
|
|
●
|
Access to a market with potentially large number of transactions;
|
|
●
|
Legal model compliant with local regulations;
|
|
●
|
Access to partner network of financial advisors or accountants (top-30 in a country);
|
|
●
|
Access to partnerships with incubators;
|
|
●
|
Access to partnerships with local business angel networks; and
|
|
●
|
Local team available with experience in corporate finance and business financing.
|
|
●
|
Associate their brands with Symbid/crowdfunding;
|
|
●
|
Get access to Symbid’s user base for special offers and deals;
|
|
●
|
Use Symbid as an outsourced R&D department within this new market; and
|
|
●
|
Get database access for research purposes.
|
|
ü
|
Does the partner add significant added value to Symbid’s offering
?
|
|
ü
|
Will the partner increase significantly the reach and accessibility of Symbid?
|
|
ü
|
Will the partner service support the growth of the average value per transaction?
|
|
●
|
Symbid believes that the vision of crowdfunding is one of cooperation and people making things happen together. This vision is best expressed through a cooperative structure under Dutch law that embraces a vision of members working together for each other;
|
|
●
|
The cooperative structure provides the framework to more easily make our customers, entrepreneurs and investors, members of a community; and
|
|
●
|
The mechanics for adding new members to a Dutch cooperative enable us complete all Symbid related investment transactions over the internet, without any off-line interaction with investors.
|
|
|
Donation based crowdfunding:
Donations made online to a specific project or cause without a prospective return.
|
|
|
Pre-sales crowdfunding:
Donations made online to a specific project or cause with the prospective of a return in the form of a product or service, when the project is successful.
|
|
|
|
|
|
Equity crowdfunding:
Investments made online in specific investment proposals with a prospective return in dividends and benefits form the value creation.
|
| ● |
risks that we may not have sufficient capital to achieve our growth strategy;
|
| ● |
risks that we may not develop our product and service offerings in a manner that enables us to be profitable and meet our customers’ requirements;
|
| ● |
risks that our growth strategy may not be successful; and
|
| ● |
risks that fluctuations in our operating results will be significant relative to our revenues.
|
|
●
|
that a broker or dealer approve a person’s account for transactions in penny stocks; and
|
|
●
|
the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.
|
|
●
|
Obtain financial information and investment experience objectives of the person; and
|
|
●
|
make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.
|
|
●
|
the basis on which the broker or dealer made the suitability determination; and
|
|
●
|
that the broker or dealer received a signed, written agreement from the investor prior to the transaction.
|
|
●
|
actual or anticipated variations in our operating results;
|
|
●
|
announcements of developments by us or our competitors;
|
|
●
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
|
|
●
|
adoption of new accounting standards affecting our Company’s industry;
|
|
●
|
additions or departures of key personnel;
|
|
●
|
sales of our Common Stock or other securities in the open market; and
|
|
●
|
other events or factors, many of which are beyond our control.
|
|
●
|
Options granted under the 2013 Plan entitle the grantee, upon exercise, to purchase a specified number of shares from us at a specified exercise price per share. The exercise price for shares of our Common Stock covered by an option generally cannot be less than the fair market value of our Common Stock on the date of grant unless agreed to otherwise at the time of the grant. In addition, in the case of an incentive stock option granted to an employee who, at the time the incentive stock option is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company or any parent or subsidiary, the per share exercise price will be no less than 110% of the fair market value of our Common Stock on the date of grant.
|
|
●
|
Restricted stock awards and restricted stock units may be awarded on terms and conditions established by the compensation committee, which may include performance conditions for restricted stock awards and the lapse of restrictions on the achievement of one or more performance goals for restricted stock units.
|
|
●
|
The compensation committee may make performance grants, each of which will contain performance goals for the award, including the performance criteria, the target and maximum amounts payable, and other terms and conditions.
|
|
●
|
The 2013 Plan authorizes the granting of stock awards. The compensation committee will establish the number of shares of our Common Stock to be awarded and the terms applicable to each award, including performance restrictions.
|
|
●
|
Stock appreciation rights (“SARs”) entitle the participant to receive a distribution in an amount not to exceed the number of shares of our Common Stock subject to the portion of the SAR exercised multiplied by the difference between the market price of a share of our Common Stock on the date of exercise of the SAR and the market price of a share of our Common Stock on the date of grant of the SAR.
|
|
1.
|
Registration Fee
(until 12/31/2012) – Approximately $327 per portfolio company to list on the Platform
|
|
2.
|
Administration Fee
– A fee is charged to investors for investments. The revenue is recognized monthly based upon transactions (i.e. investments) that occurred during the period.
|
|
a.
|
2.5% Fee charged for investments up to $6,550
|
|
b.
|
1% fee charged for investments exceeding $6,550
|
|
3.
|
Success Fee
– An approximate success fee of 3- 5% is charged by the Company for a successful private placement. The fee and revenue is recognized when the funding is completed, subject to all requirements needed.
|
|
4.
|
Refund Fee
–If an investor requests a refund from the “Online Wallet” a fee is charged to the investor in the amount of approximately $27.50 (€ 20), of which the Company will receive approximately $6.55. Revenue is recognized at the moment InterSolve sends a credit invoice to Symbid, acknowledging the refunds as complete and paid out to the customer.
|
|
5.
|
Paying method
fee
– If an investor uses a certain payment method (i.e., Pay Pal) an additional amount is charged to the customer to account for processing fees incurred by the Company. This amount is typically negligible.
|
|
1.
|
(White label) licenses
– Entered into with third party for one time upfront payment and an earn-out period of approximately 3 years. The earn-out is based upon the income earned through crowd-funding over the period
|
|
2.
|
Affiliate URL and Group licenses
– Symbid offers owners of existing communities or groups a crowdfunding service so they do not require their own crowdfunding infrastructure. Prices range from $700 to $2,500 on a yearly basis.
|
|
3.
|
Website consultancy
– Typically, the white label portals relate to crowd “voting” – A typical contract would be with the city of Rotterdam to host a vote with residents of the city to determine which particular project should get funded (public works projects).
|
|
a.
|
Symbid performs the following services for approximately EUR 6,550 to 19,650. The projects typically are less than one year. Invoicing typically 50% upfront and the remainder at the conclusion.
|
|
i.
|
Front-end user portal
|
|
ii.
|
Implementing and designing the website
|
|
iii.
|
Setup back end
|
|
iv.
|
Hosting and Support
|
|
Year Ended
|
||||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net Revenues
|
||||||||
|
Crowd funding
|
$ | 66,716 | $ | 50,319 | ||||
|
Other
|
12,714 | 57,418 | ||||||
| 79,430 | 107,737 | |||||||
|
Operating expenses
|
||||||||
|
Selling general and administrative
|
427,103 | 290,395 | ||||||
|
Professional fees
|
795,615 | 97,332 | ||||||
|
Research and development costs
|
78,773 | 165,357 | ||||||
|
Depreciation and amortization
|
1,302 | 979 | ||||||
| 1,302,793 | 554,063 | |||||||
|
Operating loss
|
(1,223,363 | ) | (446,326 | ) | ||||
|
Other income (expenses)
|
||||||||
|
Fair value adjustment derivative liability
|
1,341 | - | ||||||
|
Interest income
|
- | 3,335 | ||||||
|
Interest expenses
|
(20,166 | ) | (15,688 | ) | ||||
|
Government subsidy
|
31,905 | 20,885 | ||||||
|
Gain on sale of 450 common shares of Gambitious B.V.
|
- | 19,345 | ||||||
|
Equity in losses of Gambitious B.V.
|
(49,913 | ) | (86,492 | ) | ||||
| (36,833 | ) | (58,615 | ) | |||||
|
Net loss
|
(1,260,196 | ) | (504,941 | ) | ||||
|
Net loss attributable to non-controlling interests
|
(30,016 | ) | (64,562 | ) | ||||
|
Net loss attributable to Symbid Corp. shareholders
|
$ | (1,230,180 | ) | $ | (440,379 | ) | ||
|
Basic and diluted loss per common share
|
$ | (0.05 | ) | $ | (0.02 | ) | ||
|
Weighted average number of shares outstanding
|
||||||||
|
Basic and diluted
|
22,580,549 | 20,409,933 | ||||||
|
●
|
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
|
|
●
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
|
|
●
|
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
|
●
|
Assuming we are able to secure additional working capital, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us.
|
|
●
|
We also plan to appoint one or more outside directors to our board of directors who shall be appointed to an audit committee resulting in a fully functioning audit committee which will undertake the oversight in the establishment and monitoring of required internal controls and procedures such as reviewing and approving estimates and assumptions made by management.
|
|
Name
|
Age
|
Position
|
Date Named to Board of Directors/as Executive Officer
|
|||
|
Korstiaan Zandvliet
|
29
|
Director, Chief Executive Officer and president
|
December 6, 2013
|
|||
|
Robin Slakhorst
|
30
|
Director, Chief Commercial Officer and Secretary
|
December 6, 2013
|
|||
|
Maarten van der Sanden
|
28
|
Chief Financial Officer and Treasurer
|
December 6, 2013
|
|
●
|
any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
|
|
●
|
any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offences);
|
|
●
|
being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; or
|
|
●
|
being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
|
|
Name & Principal Position
|
Fiscal Year ended December 31,
|
Salary
($)
|
Bonus
($)
|
Stock Awards
($)
|
Option Awards
($)
|
Non-Equity Incentive Plan Compensation
($)
|
Non-Qualified Deferred Compensation Earnings
($)
|
All Other Compensation
($)
|
Total
($)
|
|||||||||||||||||||||||||
|
Korstiaan Zandvliet
(1)
|
2013 | $ | 62,818 | 0 | 0 | 0 | 0 | 0 | 0 | $ | 62,818 | |||||||||||||||||||||||
| 2012 | $ | 54,827 | 0 | 0 | 0 | 0 | 0 | 0 | $ | 54,827 | ||||||||||||||||||||||||
|
Noah Levinson (2)
|
2013 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||||||||
| 2012 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||||||
|
Holli Morris (3)
|
2013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
| 2012 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||||||
|
Maarten van der Sanden (4)
|
2013 | $ | 62,257 | 0 | 0 | 0 | 0 | 0 | 0 | $ | 62,257 | |||||||||||||||||||||||
| 2012 | $ | 40,467 | 0 | 0 | 0 | 0 | 0 | 0 | $ | 40,467 | ||||||||||||||||||||||||
|
(1)
|
On December 6, 2013, Mr. Zandvliet was appointed as our Chief Executive Officer and President. The numbers presented in this table represent compensation paid to Mr. Zandvliet by Symbid B.V. and the December 2013 salary paid by the Company.
|
|
(2)
|
On December 6, 2013, Mr. Levinson resigned as our sole officer and director. Mr. Levinson was appointed to these positions on May 14, 2013. My Levinson received $5,000 in cash compensation for services rendered to the Company in 2013.
|
|
(3)
|
On May 14, 2013, Ms. Morris resigned as our sole officer and director.
|
|
(4)
|
On December 6, 2013, Mr. van der Sanden was appointed as our Chief Financial Officer and Treasurer. The numbers presented in this table represent compensation paid to Mr. van der Sanden by Symbid B.V. and the December 2013 salary paid by the Company.
|
|
Name and Address of Beneficial Owner
|
Common Stock Beneficially Owned
|
Percent of Common Stock Beneficially Owned
(1)
|
||||||
|
Korstiaan Zandvliet
|
2,175,529 | (2) | 6.3 | % | ||||
|
Robin Slakhorst
|
2,245,240 | (3) | 6.6 | % | ||||
|
Maarten van der Sanden
|
2,210,040 | (4) | 6.4 | % | ||||
|
All directors and executive officers as a group (3 persons)
|
6,630,810 | 19.3 | % | |||||
|
Maarten Timmerman
|
6,327,083 | (5) | 18.5 | % | ||||
|
(1)
|
Applicable percentage ownership is based on 34,657,538 shares of Common Stock outstanding as of April
11
, 2014, together with securities exercisable or convertible into shares of common stock within 60 days of
April 11
, 2014, for each shareholder. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of Common Stock issuable pursuant to the exercise or conversion of other securities are deemed outstanding for the purpose of computing the percentage of ownership of the security holder, but are not treated as outstanding for the purpose of computing the percentage of ownership of any other person.
|
|
(2)
|
Consists of shares of common stock held by Arena Amnis B.V. Korstiaan Zandvliet has sole voting and investment power with respect to these shares. Includes up to 822,118 shares of Common Stock that are being held in escrow in connection with the Company’s planned acquisitions of Gambitious B.V. and Equidam Holding B.V. and that will be either cancelled or distributed (net of the number of shares used to acquire Gambitious and Equidam) to Arena Amnis B.V. as part of pro rata distribution to the pre-Share Exchange stockholders of Symbid Holding B.V. of the net number of shares available, if any, upon completion of the acquisitions, in either case within six months from the date hereof.
|
|
(3)
|
Consists of shares of common stock held by Gastropoda Equus B.V. Robin Slakhorst has sole voting and investment power with respect to these shares. Includes up to 848,461 shares of Common Stock that are being held in escrow in connection with the Company’s planned acquisitions of Gambitious B.V. and Equidam Holding B.V. and that will be either cancelled or distributed (net of the number of shares used to acquire Gambitious and Equidam) to Gastropoda Equus B.V. as part of pro rata distribution to the pre-Share Exchange stockholders of Symbid Holding B.V. of the net number of shares available, if any, upon completion of the acquisitions, in either case within six months from the date hereof.
|
|
(4)
|
Consists of shares of common stock held by Sanden Beheer B.V. Maarten van der Sanden has sole voting and investment power with respect to these shares. Includes up to 835,159 shares of Common Stock that are being held in escrow in connection with the Company’s planned acquisitions of Gambitious B.V. and Equidam Holding B.V. and that will be either cancelled or distributed (net of the number of shares used to acquire Gambitious and Equidam) to Sanden Beheer B.V. as part of pro rata distribution to the pre-Share Exchange stockholders of Symbid Holding B.V. of the net number of shares available, if any, upon completion of the acquisitions, in either case within six months from the date hereof.
|
|
(5)
|
Consists of 5,202,083 shares of common stock held by Zomer B.V. and 1,250,000 shares of common stock held by Voyager Beheer B.V. Maarten Timmerman has sole voting and investment power with respect to these shares. Includes up to 1,965,832 shares of Common Stock that are being held in escrow in connection with the Company’s planned acquisitions of Gambitious B.V. and Equidam Holding B.V. and that will be either cancelled or distributed (net of the number of shares used to acquire Gambitious and Equidam) to Zomer B.V. to the pre-Share Exchange stockholders of Symbid Holding B.V. of the net number of shares available, if any, upon completion of the acquisitions, in either case within six months from the date hereof.
|
|
Plan Category
|
Number of securities to
be issued upon
exercise of outstanding options,
warrants and rights
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
|
Number of securities
remaining available for
future issuance under
equity
compensation plans
(excluding securities
reflected
in column (a))
|
||||||
|
(a)
|
(b)
|
(c)
|
|||||||
|
Equity compensation plans approved by security holders
|
0
|
N/A
|
5,000,000
|
||||||
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
||||||
|
Total
|
0
|
N/A
|
5,000,000
|
||||||
|
Fee Category
|
Year ended
December 31, 2013
|
Year ended
December 31, 2012
|
||||||
|
Audit fees (1)
|
$ | 127,167 | $ | 7,000 | ||||
|
Audit-related fees (2)
|
0 | 0 | ||||||
|
Tax fees (3)
|
0 | 0 | ||||||
|
All other fees (4)
|
0 | 0 | ||||||
|
Total fees
|
$ | 127,167 | $ | 7,000 | ||||
|
(1)
|
Audit fees consist of fees incurred for professional services rendered for the audit of consolidated financial statements, for reviews of our interim consolidated financial statements included in our quarterly reports on Form 10-Q and for services that are normally provided in connection with statutory or regulatory filings or engagements.
|
|
(2)
|
Audit-related fees consist of fees billed for professional services that are reasonably related to the performance of the audit or review of our consolidated financial statements, but are not reported under “Audit fees.”
|
|
(3)
|
Tax fees consist of fees billed for professional services relating to tax compliance, tax planning, and tax advice.
|
|
(4)
|
All other fees consist of fees billed for all other services.
|
|
●
|
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
●
|
have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
|
|
●
|
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
|
|
●
|
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
|
|
Exhibit
Number
|
Description
|
||||||
|
2.1
|
Share Exchange Agreement dated December 6, 2013, by and among Symbid Corp., Symbid Holding B.V. and the Shareholders of Symbid Holding B.V (1)
|
||||||
|
3.1
|
Articles of Incorporation of the Registrant (2)
|
||||||
|
3.2
|
Certificate of Amendment to the Articles of Incorporation of the Registrant (3)
|
||||||
|
3.3
|
By-Laws of the Registrant
(incorporated by reference from Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1 filed with the SEC on October 25, 2011) (4)
|
||||||
|
3.4
|
Articles of Association of Symbid Cooperatie U.A. (Unofficial English Translation) (5)
|
||||||
|
3.5
|
Articles of Association of Symbid Foundation. (Unofficial English Translation) (5)
|
||||||
|
3.6
|
Articles of Association of Symbid IP Foundation. (Unofficial English Translation) (5)
|
||||||
|
4.1
|
Form of Investor Warrant of the Registrant (1)
|
||||||
|
4.2
|
Form of Broker Warrant of the Registrant (1)
|
||||||
|
10.1
|
Split-Off Agreement, dated as of December 6, 2013, by and among the Registrant, Symbid Split Corp. and Holli Morris (1)
|
||||||
|
10.2
|
General Release Agreement, dated as of December 6, 2013, by and among the Registrant, Symbid Split Corp. and Holli Morris (1)
|
||||||
|
10.3
|
Form of Lock-Up and No Short Selling Agreement between the Registrant and the officers, directors and shareholders party thereto (1)
|
||||||
|
10.4
|
Form of Securities Purchase Agreement between the Registrant and the investors party thereto (1)
|
||||||
|
10.5
|
Form of Notice to Investors dated November 25, 2013 (1)
|
||||||
|
10.6
|
Placement Agency Agreement, dated September 9, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||||||
|
10.7
|
Placement Agency Agreement, First Amendment, dated October 14, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||||||
|
10.8
|
Placement Agency Agreement, Second Amendment, dated November 15, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||||||
|
10.9
|
Subscription Escrow Agreement, dated as of September 9, 2013, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital markets, LLC (1)
|
||||||
|
10.10
|
Subscription Escrow Agreement, First Amendment dated as of November 15, 2013, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital markets, LLC (1)
|
||||||
|
10.11
|
Escrow Agreement dated as of December 6, 2013 by and among the Registrant, the Indemnification and Shareholder Representative named therein and Gottbetter & Partners, LLP (1)
|
||||||
|
10.12†
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Korstiaan Zandvliet (1)
|
||||||
|
10.13†
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Robin Slakhorst (1)
|
||||||
|
10.14†
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Maarten van der Sanden(1)
|
||||||
|
10.15†
|
The Registrant’s 2013 Equity Incentive Plan(1)
|
||||||
|
10.16†
|
Form of Registration Rights Agreement (1)
|
||||||
|
10.17
|
License Agreement dated April 13, 2011 by and between Symbid B.V. and Symbid Cooperatie U.A. (1)
|
||||||
|
10.18
|
Platform management Services Agreement April 6, 2011 by and between Symbid B.V. and Symbid Cooperatie U.A. (1)
|
||||||
|
10.19
|
Intellectual Property Transfer Agreement dated October 16, 2013 by and between Symbid B.V. and Stichting Symbid IP Foundation (1)
|
||||||
|
10.20
|
Intellectual Property License and Transfer Agreement dated October 16, 2013 by and between Stichting Symbid IP Foundation and Symbid Holding B.V. (1)
|
||||||
|
10.21
|
Addendum 1 dated December 5, 2013 to Intellectual Property License and Transfer Agreement dated October 16, 2013 by and between Stichting Symbid IP Foundation and Symbid Holding B.V. (1)
|
||||||
|
10.22
|
Intellectual Property Sublicense and Transfer Agreement dated December 5, 2013 by and between Symbid Holding B.V. and Symbid B.V. (1)
|
||||||
|
14.1
|
Code of Ethics (2)
|
||||||
|
21.1*
|
Subsidiaries of Registrant
|
||||||
|
31.1
|
*
|
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||||
|
31.2
|
*
|
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||||
|
32.1
|
*
|
Certifications of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|||||
|
32.2
|
*
|
Certifications of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|||||
|
101.INS
|
*
|
XBRL Instance Document***
|
|||||
|
101.SCH
|
*
|
XBRL Taxonomy Extension Schema Document***
|
|||||
|
101.CAL
|
*
|
XBRL Taxonomy Extension Calculation Linkbase Document***
|
|||||
|
101.DEF
|
*
|
XBRL Taxonomy Extension Definition Linkbase Document***
|
|||||
|
101.LAB
|
*
|
XBRL Taxonomy Extension Label Linkbase Document***
|
|||||
|
101.PRE
|
*
|
XBRL Taxonomy Extension Presentation Linkbase Document***
|
|||||
|
(1)
|
Filed with the Securities and Exchange Commission on December 12, 2013, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K ), which exhibit is incorporated herein by reference.
|
|
(2)
|
Filed with the Securities and Exchange Commission on October 25, 2011, as an exhibit, numbered as indicated above, to the Registrant’s Registration Statement on Form S-1, which exhibit is incorporated herein by reference.
|
|
(3)
|
Filed with the Securities and Exchange Commission on September 9, 2013, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K filed with the SEC on September 9, 2013, which exhibit is incorporated herein by reference.
|
|
(4)
|
Filed with the Securities and Exchange Commission on October 25, 2011, as exhibit numbered 3.2, to the Registrant’s Registration Statement on Form S-1, which exhibit is incorporated herein by reference.
|
|
(5)
|
Filed with the Securities and Exchange Commission on March 13, 2014, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K, Amendment No. 1, which exhibit is incorporated herein by reference.
|
|
SYMBID CORP.
|
|||
|
Dated: April 14, 2014
|
By:
|
/s/ Korstiaan Zandvliet | |
| Name: Korstiaan Zandvliet | |||
|
Title: President
(Principal Executive Officer)
|
|||
|
By:
|
/s/ Maarten van der Sanden | ||
| Name: Maarten van der Sanden | |||
|
Title:
Treasurer
(Principal Financial Officer)
|
|||
| Signature | Title | Date | ||
| /s/ Korstiaan Zandvliet |
April 14, 2014
|
|||
|
Korstiaan Zandvliet
|
Director
|
|||
|
/s/ Robin Slakhorst
|
April 14, 2014
|
|||
|
Robin Slakhorst
|
Secretary and Director
|
|
Report of Independent Registered Public Accounting Firm
|
F–1 | |||
|
Consolidated Balance Sheets
|
F–2 | |||
|
Consolidated Statements of Operations
|
F–3 | |||
|
Consolidated Statements of Comprehensive Loss
|
F–4 | |||
|
Consolidated Statements of Stockholders’ Deficit
|
F–5 | |||
|
Consolidated Statements of Cash Flows
|
F–6 | |||
|
Notes to Consolidated Financial Statements
|
F–7 |
|
/s/ Friedman LLP
|
|
|
East Hanover, New Jersey
|
|
|
April 14, 2014
|
|
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 891,592 | $ | 7,732 | ||||
|
Accounts receivable, less allowance for doubtful accounts of $10,718 and $0 respectively
|
2,897 | 6,033 | ||||||
|
Prepaid expenses and other current assets
|
59,486 | 32,183 | ||||||
|
Total current assets
|
953,975 | 45,948 | ||||||
|
Property and equipment - at cost, less accumulated
|
||||||||
|
depreciation and amortization
|
4,259 | 5,365 | ||||||
|
Investment in Equidam Holding B.V.
|
1,432 | 49,462 | ||||||
| $ | 959,666 | $ | 100,775 | |||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$ | 138,495 | $ | 50,703 | ||||
|
Accrued expenses and other current liabilities
|
256,928 | 58,270 | ||||||
|
Deferred government grants
|
11,017 | 42,156 | ||||||
|
Current maturities of notes payable
|
41,657 | 126,812 | ||||||
|
Total current liabilities
|
448,097 | 277,941 | ||||||
|
Notes payable, less current maturities
|
237,973 | 267,547 | ||||||
|
Derivative liability - warrants
|
303,662 | - | ||||||
| Total Liabilities | 989,732 | 545,488 | ||||||
|
Commitments
|
||||||||
|
Stockholders' deficit
|
||||||||
|
Preferred stock
|
||||||||
|
Authorized: $0.001 par value, 10,000,000 shares authorized
|
- | - | ||||||
|
Issued and outstanding: nil preferred shares
|
||||||||
|
Common stock
|
||||||||
|
Authorized: $0.001 par value, 290,000,000 shares authorized
|
||||||||
|
Issued and outstanding: 34,268,736 and 26,733,356 respectively
|
34,268 | 26,733 | ||||||
|
Additional paid-in capital
|
2,041,052 | 335,655 | ||||||
|
Accumulated other comprehensive loss
|
(44,029 | ) | (7,705 | ) | ||||
|
Accumulated deficit
|
(2,001,760 | ) | (771,580 | ) | ||||
| Equity attributable to Symbid Corp. Stockholders | 29,531 | (416,897 | ) | |||||
|
Noncontrolling interests
|
(59,597 | ) | (27,816 | ) | ||||
| Total Equity | (30,066 | ) | (444,713 | ) | ||||
| Total Liabilities and Equity | $ | 959,666 | $ | 100,775 | ||||
|
(The accompanying notes are an integral part of these consolidated financial statements)
|
|
Year Ended
|
||||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net Revenues
|
||||||||
|
Crowd funding
|
$ | 66,716 | $ | 50,319 | ||||
|
Other
|
12,714 | 57,418 | ||||||
| 79,430 | 107,737 | |||||||
|
Operating expenses
|
||||||||
|
Selling general and administrative
|
427,103 | 290,395 | ||||||
|
Professional fees
|
795,615 | 97,332 | ||||||
|
Research and development costs
|
78,773 | 165,357 | ||||||
|
Depreciation and amortization
|
1,302 | 979 | ||||||
| 1,302,793 | 554,063 | |||||||
|
Operating loss
|
(1,223,363 | ) | (446,326 | ) | ||||
|
Other income (expenses)
|
||||||||
|
Fair value adjustment derivative liability
|
1,341 | - | ||||||
|
Interest income
|
- | 3,335 | ||||||
|
Interest expenses
|
(20,166 | ) | (15,688 | ) | ||||
|
Government subsidy
|
31,905 | 20,885 | ||||||
|
Gain on sale of 450 common shares of Gambitious B.V.
|
- | 19,345 | ||||||
|
Equity in losses of Gambitious B.V.
|
(49,913 | ) | (86,492 | ) | ||||
| (36,833 | ) | (58,615 | ) | |||||
|
Net loss
|
(1,260,196 | ) | (504,941 | ) | ||||
|
Net loss attributable to non-controlling interests
|
(30,016 | ) | (64,562 | ) | ||||
|
Net loss attributable to Symbid Corp. shareholders
|
$ | (1,230,180 | ) | $ | (440,379 | ) | ||
|
Basic and diluted loss per common share
|
$ | (0.05 | ) | $ | (0.02 | ) | ||
|
Weighted average number of shares outstanding
|
||||||||
|
Basic and diluted
|
22,580,549 | 20,909,933 | ||||||
|
Year Ended
|
||||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net loss
|
$ | (1,260,196 | ) | $ | (504,941 | ) | ||
|
Other comprehensive loss:
|
||||||||
|
Foreign currency translation adjustments
|
(36,324 | ) | (3,885 | ) | ||||
|
Comprehensive loss
|
(1,296,520 | ) | (508,826 | ) | ||||
|
Net loss attributable to non-controlling interests
|
(30,016 | ) | (64,562 | ) | ||||
|
Foreign currency translation income attributable to non-controlling interests
|
(1,765 | ) | (64 | ) | ||||
|
Comprehensive loss attributable to non-controlling interests
|
(31,781 | ) | (64,626 | ) | ||||
|
Comprehensive loss attributable to Symbid Corp. shareholders
|
$ | (1,264,739 | ) | $ | (444,200 | ) | ||
|
Symbid Corp. Shareholders
|
||||||||||||||||||||||||||||||||
|
Additional
|
Accumulated
Other
|
Total Symbid Corp.
|
||||||||||||||||||||||||||||||
|
Number of
|
Common
|
Paid-In
|
Comprehensive
|
Accumulated
|
Shareholders'
|
Noncontrolling
|
Total
|
|||||||||||||||||||||||||
|
Shares
|
Stock
|
Capital
|
Loss
|
Deficit
|
Equity
|
Interest
|
Equity
|
|||||||||||||||||||||||||
|
Balance, January 1, 2012
|
26,733,356 | 26,733 | 253,931 | (3,884 | ) | (331,201 | ) | (54,421 | ) | (13,586 | ) | (68,007 | ) | |||||||||||||||||||
|
Proceeds from the sale of Gambitious cooperative common stock
|
- | - | 81,724 | - | - | 81,724 | 50,396 | 132,120 | ||||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | (3,821 | ) | - | (3.821 | ) | (64 | ) | (3,885 | ) | ||||||||||||||||||||
|
Net loss
|
- | - | - | - | (440,379 | ) | (440,379 | ) | (64,562 | ) | (504,941 | ) | ||||||||||||||||||||
|
Balance, December 31, 2012
|
26,733,356 | 26,733 | 335,655 | (7,705 | ) | (771,580 | ) | (416,897 | ) | (27,816 | ) | (444,713 | ) | |||||||||||||||||||
|
Proceeds from the issuance of common stock, net of issuance costs
|
3,198,414 | 3,198 | 375,025 | - | - | 378,223 | - | 378,223 | ||||||||||||||||||||||||
|
Issue of common stock, PPO
|
3,098,736 | 3,099 | 1,180,125 | - | - | 1,183,224 | - | 1,183,224 | ||||||||||||||||||||||||
|
Issue of common stock for services
|
501,780 | 502 | 65,302 | - | - | 65,804 | - | 65,804 | ||||||||||||||||||||||||
|
Non-cash conversion of Notes Payable
|
736,450 | 736 | 84,945 | - | - | 85,681 | - | 85,681 | ||||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | (36,324 | ) | - | (36,324 | ) | (1,765 | ) | (38,089 | ) | ||||||||||||||||||||
|
Net loss
|
- | - | - | - | (1,230,180 | ) | (1,230,180 | ) | (30,016 | ) | (1,260,196 | ) | ||||||||||||||||||||
|
Balance, December 31, 2013
|
34,268,736 | 34,268 | 2,041,052 | (44,029 | ) | (2,001,760 | ) | 29,531 | (59,597 | ) | (30,066 | ) | ||||||||||||||||||||
|
Year Ended
|
||||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Cash flows from operating activities
|
||||||||
|
Net loss
|
$ | (1,260,196 | ) | $ | (504,941 | ) | ||
|
Adjustments to reconcile net loss to net cash
|
||||||||
|
used in operating activities
|
||||||||
|
Depreciation and amortization
|
1,302 | 979 | ||||||
|
Gain on sale of stock of Gambititous B.V.
|
- | (19,345 | ) | |||||
|
Losses recorded from investment in Gambitious B.V.
|
49,913 | 86,492 | ||||||
|
Warrant liability
|
(1,341 | ) | - | |||||
|
Deferred government grants
|
(31,905 | ) | - | |||||
|
Provision for doubtful accounts
|
10,349 | - | ||||||
|
Changes in assets and liabilities
|
||||||||
|
Accounts receivables
|
(7,056 | ) | 1,627 | |||||
|
Prepaid expenses and other current assets
|
41,516 | (16,579 | ) | |||||
|
Accounts payable
|
82,553 | (564 | ) | |||||
|
Accrued expenses and other current liabilities
|
189,264 | 38,693 | ||||||
|
Deferred government grants
|
- | 41,769 | ||||||
|
Net cash used in operating activities
|
(925,601 | ) | (371,869 | ) | ||||
|
Cash flows from investing activities
|
||||||||
|
Investment in Equidam Holding B.V.
|
$ | (1,376 | ) | $ | - | |||
|
Investment in Gambitious B.V.
|
- | (132,099 | ) | |||||
|
Cash proceeds from sale of stock of Gambitious B.V.
|
- | 19,581 | ||||||
|
Purchase of property and equipment
|
- | (2,758 | ) | |||||
|
Net cash used in investing activities
|
(1,376 | ) | (115,276 | ) | ||||
|
Cash flows from financing activities
|
||||||||
|
Proceeds from private placement
|
$ | 1,489,118 | $ | 132,120 | ||||
|
Proceeds from capital contribution
|
378,223 | - | ||||||
|
Proceeds from the issuance of notes payable
|
- | 322,922 | ||||||
|
Repayments of notes payable
|
(41,623 | ) | (19,763 | ) | ||||
|
Net cash provided by financing activities
|
1,825,718 | 435,279 | ||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(14,881 | ) | 4,856 | |||||
|
Net increase (decrease) in cash and cash equivalents
|
883,860 | (47,010 | ) | |||||
|
Cash and cash equivalents, beginning of year
|
7,732 | 54,742 | ||||||
|
Cash and cash equivalents, end of year
|
$ | 891,592 | $ | 7,732 | ||||
|
Supplemental cash flow disclosures
|
||||||||
|
Interest paid
|
$ | (20,166 | ) | $ | (15,688 | ) | ||
|
Non-cash financing activities
|
||||||||
|
Conversion of Notes Payable into common stock
|
$ | 85,681 | $ | - | ||||
|
Issuance of common stock for services
|
65,804 | - | ||||||
| Fair value of warrant liability | 221,533 | - | ||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Current assets
|
$ | 53,414 | $ | 21,940 | ||||
|
Current liabilities
|
$ | 113,137 | $ | 69,225 | ||||
|
December 31,
|
|
||||||||
|
Prepaid expenses and other current assets
|
2013
|
2012
|
|
||||||
|
VAT return Q4 2013/ 2012
|
$ | 40,232 | $ | 23,944 | |||||
|
Guarantee
|
- | 5,684 | |||||||
|
Revenues to be invoiced
|
9,273 | - | |||||||
|
Interest loan January 2014
|
1,090 | - | |||||||
|
Other prepaid expenses
|
1,747 | 2,318 | |||||||
|
Sharpe - prepaid advisory costs
|
7,144 | 237 | |||||||
| $ | 59,486 | $ | 32,183 | ||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Computer and equipment
|
$ | 6,446 | $ | 6,446 | ||||
|
Less - Accumulated depreciation and amortization
|
(2,187 | ) | (1,081 | ) | ||||
| $ | 4,259 | $ | 5,365 | |||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Current assets
|
$ | 45,432 | $ | 207,414 | ||||
|
Property and equipment
|
- | - | ||||||
| $ | 45,432 | $ | 207,414 | |||||
|
Current liabilities
|
$ | 87,537 | $ | 33,861 | ||||
|
Stockholders’ equity
|
(42,105 | ) | 173,553 | |||||
| $ | 45,432 | $ | 207,414 | |||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Sales
|
$ | 21,994 | $ | - | ||||
|
Expenses, net
|
(240,661 | ) | (287,956 | ) | ||||
|
Net loss
|
$ | (218,667 | ) | $ | (287,956 | ) | ||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Working capital facility - term loan
|
$ | 187,371 | $ | 219,198 | ||||
|
Note payable – related party
|
- | 86,955 | ||||||
|
Subordinated loan – related party
|
92,259 | 88,206 | ||||||
| 279,630 | 394,359 | |||||||
|
Less - Current Maturities
|
(41,657 | ) | (126,812 | ) | ||||
| $ | 237,973 | $ | 267,547 | |||||
|
1.
|
Long term loan for approximately $ 240,000, bears interest of approximately 6.4% and is payable quarterly with principal. The loan decreases on a quarterly basis by approximately $ 10,000, starting on September 30, 2012. As of December 31, 2013 the loan balance was $ 187,371.
|
|
2.
|
A line of credit of approximately $ 80,000 with a floating interest rate of approximately 4.5% at December 31, 2013. The balance on the credit facility at December 31, 2013 and 2012 was $ 0.
|
|
1.
|
Assets of the Company including receivables and intellectual property developed by the Company.
|
|
2.
|
Guarantee by principal members of management up to approximately $ 60,000.
|
|
3.
|
Guaranteed by the Netherlands government for the remaining balance in a hypothetical liquidation up to approximately $ 264,000.
|
|
Year Ending
|
||||
|
December 31
|
||||
|
2014
|
$ | 41,657 | ||
|
2015
|
132,627 | |||
|
2016
|
41,657 | |||
|
2017
|
41,657 | |||
|
2018
|
22,032 | |||
| $ | 279,630 | |||
| Total value: | $ | 1,549,368 | ||
| Issuance costs: | (60,250 | ) | ||
| Warrants: | (305,893 | ) | ||
| $ | 1,183,225 |
|
December 31,
|
|||||||||
|
2013
|
2012
|
||||||||
|
Symbid Coop - 100%
|
$ | 9,792 | $ | 33,142 | |||||
|
Gambitious Coop - 37%
|
20,224 | 31,420 | |||||||
|
Total net loss attributable to NCI
|
$ | 30,016 | $ | 64,562 | |||||
|
|
December 6,
|
December 31,
|
||||||
|
|
2013
|
2013
|
||||||
|
Warr Investor Warrants
|
||||||||
|
Implied starting stock price
|
$ | 0.42 | $ | 0.42 | ||||
|
Volatility
|
55 | % | 55 | % | ||||
|
Drift
|
0.64 | % | 0.75 | % | ||||
|
Exercise price
|
$ | 0.75 | $ | 0.75 | ||||
|
Minimum exercise price
|
$ | 0.01 | $ | 0.01 | ||||
|
Warrant shares
|
3,098,736 | 3,098,736 | ||||||
|
Event date
|
September 30, 2014
|
September 30, 2014
|
||||||
|
Maturity
|
December 5, 2016
|
December 5, 2016
|
||||||
|
Shares outstanding
|
34,268,736 | 34,268,736 | ||||||
|
|
December 6,
|
December 31,
|
||||||
|
|
2013
|
2013
|
||||||
|
Bro Broker Warrants
|
||||||||
|
Implied starting stock price
|
$ | 0.39 | $ | 0.42 | ||||
|
Volatility
|
55 | % | 55 | % | ||||
|
Drift
|
0.64 | % | 0.75 | % | ||||
|
Exercise price
|
$ | 0.50 | $ | 0.50 | ||||
|
Minimum exercise price
|
$ | 0.01 | $ | 0.01 | ||||
|
Warrant shares
|
77,500 | 77,500 | ||||||
|
Event date
|
September 30, 2014
|
September 30, 2014
|
||||||
|
Maturity
|
December 5, 2016
|
December 5, 2016
|
||||||
|
Shares outstanding
|
34,268,736 | 34,268,736 | ||||||
|
December 6,
|
December 31,
|
Realized
|
||||||||||
|
2013
|
2013
|
Gain/(Loss)
|
||||||||||
|
on change
|
||||||||||||
|
Fair Value of
Warrants Liabilities
|
Fair Value of
Warrants Liabilities
|
in Warrant
Liabilites
|
||||||||||
|
Investor Warrants
|
$ | 296,475 | $ | 294,298 | $ | 2,177 | ||||||
|
Broker Warrants
|
9,418 | 9,364 | 54 | |||||||||
|
Cumulative translation adjustment
|
- | - | (890 | ) | ||||||||
| $ | 305,893 | $ | 303,662 | $ | 1,341 | |||||||
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Advisory costs
|
$ | 172,051 | $ | - | ||||
|
Travel and hotel costs
|
15,272 | - | ||||||
|
Development costs
|
10,063 | - | ||||||
|
Management fee
|
- | 36,057 | ||||||
|
Interest
|
8,451 | 4,557 | ||||||
|
Wage tax' return
|
15,177 | - | ||||||
|
Holiday pay allowance/Net salary
|
17,648 | 1,611 | ||||||
|
Other current liabilities
|
18,266 | 16,045 | ||||||
| $ | 256,928 | $ | 58,270 | |||||
|
1)
|
Persuasive evidence of an arrangement exists.
|
|
2)
|
Fulfillment of the obligation has occurred or services have been rendered.
|
|
3)
|
The amount of the grant is fixed and determinable.
|
|
4)
|
Collectability is reasonably assured.
|
|
December 31,
|
||
|
2013
|
2012
|
|
|
Federal income tax rate
|
20%
|
20%
|
|
NCI – Symbid Coop
|
-
|
(.14)
|
|
NCI – Gambitious Coop
|
(.37)
|
(3.36)
|
|
Equity Method Pick-Up – Symbid Holding
|
(9.49)
|
-
|
|
Gain on capital sale of stock
|
-
|
.77
|
|
Other
|
(.07)
|
(.36)
|
|
Effective income tax rate
|
10.07
|
16.91
|
|
Effect on valuation allowance
|
(10.07)
|
(16.91)
|
|
Effective income tax rate
|
0%
|
0%
|
|
|
EXHIBIT INDEX
|
|
Exhibit No.
|
SEC
Report
Reference
No.
|
Description
|
||
|
*
|
List of Subsidiaries
|
|||
|
*
|
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||
|
*
|
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||
|
*
|
Certifications of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|||
|
*
|
Certifications of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|||
|
101.INS
|
*
|
XBRL Instance Document***
|
||
|
101.SCH
|
*
|
XBRL Taxonomy Extension Schema Document***
|
||
|
101.CAL
|
*
|
XBRL Taxonomy Extension Calculation Linkbase Document***
|
||
|
101.DEF
|
*
|
XBRL Taxonomy Extension Definition Linkbase Document***
|
||
|
101.LAB
|
*
|
XBRL Taxonomy Extension Label Linkbase Document***
|
||
|
101.PRE
|
*
|
XBRL Taxonomy Extension Presentation Linkbase Document***
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|